Get alerts when ULKER.IS reports next quarter
Set up alerts — freeUlker Biskuvi shares fell 6.6% after earnings, with the likely pressure point being a cautious, weaker reported picture: nine-month revenue declined 8.8% year on year on an inflation-adjusted basis, while consolidated volume growth was modest. The transcript provided does not include the full outlook discussion, so the specific role of guidance in the market reaction is unclear.
See ULKER.IS alongside your other holdings
Add to your portfolio — freeTrack Ulker Biskuvi Sanayi A.S. in your portfolio with real-time analytics, dividend tracking, and more.
View ULKER.IS Analysis